XNAS: FBRX
Forte Biosciences Inc Live Stock Price Today, Share Analysis and Chart
about
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimm...
Read More
23.11
-0.85
(-3.55%)
177.7K
XNAS Volume
XNAS 15 May, 2026 5:30 PM (EDT)
Board Meeting
The latest board meeting for Forte Biosciences Inc took place on 15 May 2026, for the purpose of Forte Biosciences Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Neutral
Forte Biosciences Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..